By plasma proteomics analysis of 339 samples from 112 hospitalized patients in the COMMUNITY STUDY, we found that plasma levels of PLXNA4 were associated with level of respiratory support needed in critically ill COVID-19 patients. This evidence concerns the gene PLXNA4 and COVID-19.